🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

148,46 USD

Máx. histórico

156,92

14 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-5,39%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,24%

Cierre anterior

150,33

Rango de hoy

146,28 – 149,59

Volumen hoy

10.884.998

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
118,77 (puede no estar actualizado)
Dividend yield
2,26% (puede no estar actualizado)
Precio objetivo analistas
150,42 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 7 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,26%
Fecha de pago Importe por participación
03/12/1973 0,0093 USD
31/08/1973 0,0078 USD
05/06/1973 0,0078 USD
05/03/1973 0,0078 USD
05/12/1972 0,0078 USD
09/06/1972 0,0073 USD
02/03/1972 0,0073 USD
06/12/1971 0,0073 USD
03/09/1971 0,0073 USD
07/06/1971 0,0073 USD
02/03/1971 0,0073 USD
01/12/1970 0,0073 USD
02/09/1970 0,0066 USD
02/06/1970 0,0066 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
22/09/1999 65,59 67,27 65,59 66,67 +1,64% 2,57% 6.247.442
21/09/1999 65,72 66,44 64,89 65,60 -1,96% 2,36% 4.407.993
20/09/1999 65,66 67,09 65,48 66,91 +2,09% 2,45% 2.962.382
17/09/1999 66,50 66,67 65,54 65,54 -1,08% 1,70% 5.314.198
16/09/1999 65,06 66,26 65,00 66,26 +2,02% 1,92% 3.169.781
15/09/1999 66,26 66,79 64,95 64,95 -0,73% 2,79% 4.003.779
14/09/1999 65,96 66,20 65,12 65,42 -1,53% 1,63% 3.592.230
13/09/1999 66,44 67,03 66,26 66,44 -0,27% 1,17% 3.806.755
10/09/1999 66,20 66,85 65,60 66,62 +0,90% 1,89% 3.289.672
09/09/1999 66,67 66,67 65,90 66,02 +0,00% 1,16% 3.741.884
08/09/1999 65,36 66,14 64,77 66,02 +0,54% 2,10% 7.157.526
07/09/1999 67,33 67,63 65,48 65,66 -2,39% 3,19% 3.885.984
03/09/1999 66,56 67,33 65,84 67,27 +3,30% 2,24% 4.699.861
02/09/1999 65,00 65,78 64,17 65,12 -0,91% 2,48% 3.423.082
01/09/1999 64,11 65,96 63,99 65,72 +2,51% 3,07% 3.761.167
31/08/1999 65,12 66,26 64,11 64,11 -1,38% 3,30% 4.234.444
30/08/1999 65,30 66,26 64,95 65,00 +0,00% 2,01% 2.777.934
27/08/1999 66,38 66,44 65,00 65,00 -1,00% 2,16% 3.020.441
26/08/1999 66,91 66,97 65,54 65,66 -2,39% 2,14% 3.175.545
25/08/1999 66,44 67,39 66,20 67,27 +2,17% 1,80% 4.968.987
24/08/1999 66,62 66,73 65,36 65,84 -1,52% 2,06% 4.379.382
23/08/1999 65,00 66,91 64,89 66,85 +3,60% 3,12% 6.545.913
20/08/1999 62,56 64,83 62,50 64,53 +3,24% 3,72% 5.964.902
19/08/1999 61,55 63,28 61,37 62,50 +1,06% 3,10% 4.267.246
18/08/1999 62,44 62,74 61,84 61,84 -0,29% 1,43% 3.809.061
17/08/1999 62,74 62,74 60,95 62,02 +0,29% 2,85% 3.758.757
16/08/1999 61,07 61,84 60,71 61,84 +1,67% 1,86% 4.337.253
13/08/1999 60,05 61,55 59,88 60,83 +2,82% 2,78% 7.417.849
12/08/1999 58,21 60,47 58,21 59,16 +1,74% 3,89% 10.038.897
11/08/1999 59,94 60,05 58,15 58,15 -2,11% 3,18% 5.341.237